Logo image of LXS.DE

LANXESS AG (LXS.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:LXS - DE0005470405 - Common Stock

17.245 EUR
+0.51 (+3.02%)
Last: 11/25/2025, 4:17:19 PM
Fundamental Rating

3

Taking everything into account, LXS scores 3 out of 10 in our fundamental rating. LXS was compared to 74 industry peers in the Chemicals industry. LXS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LXS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LXS was profitable.
LXS had a positive operating cash flow in the past year.
LXS had positive earnings in 4 of the past 5 years.
In the past 5 years LXS always reported a positive cash flow from operatings.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

LXS's Return On Assets of -2.97% is on the low side compared to the rest of the industry. LXS is outperformed by 71.62% of its industry peers.
LXS has a Return On Equity of -6.23%. This is in the lower half of the industry: LXS underperforms 71.62% of its industry peers.
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROIC N/A
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

LXS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 20.52%, LXS is doing worse than 67.57% of the companies in the same industry.
In the last couple of years the Gross Margin of LXS has declined.
LXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.52%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

4

2. Health

2.1 Basic Checks

LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LXS remains at a similar level compared to 1 year ago.
LXS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LXS has been reduced compared to a year ago.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 1.88 indicates that LXS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of LXS (1.88) is worse than 63.51% of its industry peers.
The Debt to FCF ratio of LXS is 22.13, which is on the high side as it means it would take LXS, 22.13 years of fcf income to pay off all of its debts.
LXS has a Debt to FCF ratio (22.13) which is in line with its industry peers.
LXS has a Debt/Equity ratio of 0.62. This is a neutral value indicating LXS is somewhat dependend on debt financing.
LXS's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. LXS is outperformed by 63.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Altman-Z 1.88
ROIC/WACCN/A
WACC4.31%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

LXS has a Current Ratio of 2.60. This indicates that LXS is financially healthy and has no problem in meeting its short term obligations.
LXS has a better Current ratio (2.60) than 77.03% of its industry peers.
A Quick Ratio of 1.29 indicates that LXS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.29, LXS is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.29
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

LXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.28%.
The earnings per share for LXS have been decreasing by -19.38% on average. This is quite bad
The Revenue has decreased by -6.82% in the past year.
The Revenue has been decreasing by -1.32% on average over the past years.
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%

3.2 Future

LXS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.66% yearly.
Based on estimates for the next years, LXS will show a small growth in Revenue. The Revenue will grow by 0.02% on average per year.
EPS Next Y-69.81%
EPS Next 2Y-11.44%
EPS Next 3Y7.01%
EPS Next 5Y11.66%
Revenue Next Year-8.19%
Revenue Next 2Y-3.81%
Revenue Next 3Y-1.46%
Revenue Next 5Y0.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.96, the valuation of LXS can be described as rather expensive.
Based on the Price/Earnings ratio, LXS is valued a bit cheaper than the industry average as 70.27% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of LXS to the average of the S&P500 Index (25.65), we can say LXS is valued slightly cheaper.
With a Price/Forward Earnings ratio of 13.92, LXS is valued correctly.
Based on the Price/Forward Earnings ratio, LXS is valued a bit cheaper than the industry average as 68.92% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.45, LXS is valued rather cheaply.
Industry RankSector Rank
PE 17.96
Fwd PE 13.92
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LXS is valued cheaply inside the industry as 83.78% of the companies are valued more expensively.
LXS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LXS is cheaper than 87.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.3
EV/EBITDA 5.88
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.44%
EPS Next 3Y7.01%

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.61%, LXS is not a good candidate for dividend investing.
The stock price of LXS dropped by -30.94% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
LXS's Dividend Yield is slightly below the industry average, which is at 3.18.
Compared to an average S&P500 Dividend Yield of 2.41, LXS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

LXS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-4.12%
EPS Next 2Y-11.44%
EPS Next 3Y7.01%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

LANXESS AG

FRA:LXS (11/25/2025, 4:17:19 PM)

17.245

+0.51 (+3.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-19 2026-03-19/amc
Inst Owners62.26%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.49B
Revenue(TTM)5.89B
Net Income(TTM)-243.00M
Analysts55.56
Price Target21.89 (26.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-4.12%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)292.85%
Min EPS beat(2)79.47%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)279.29%
Min EPS beat(4)79.47%
Max EPS beat(4)506.23%
EPS beat(8)8
Avg EPS beat(8)234.01%
EPS beat(12)11
Avg EPS beat(12)164.45%
EPS beat(16)14
Avg EPS beat(16)126.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-7.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.7%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-4.92%
Revenue beat(12)2
Avg Revenue beat(12)-4.05%
Revenue beat(16)3
Avg Revenue beat(16)-5.05%
PT rev (1m)-16.89%
PT rev (3m)-22.07%
EPS NQ rev (1m)1.16%
EPS NQ rev (3m)-61.68%
EPS NY rev (1m)194%
EPS NY rev (3m)240.19%
Revenue NQ rev (1m)-1.58%
Revenue NQ rev (3m)-5.32%
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)-3.52%
Valuation
Industry RankSector Rank
PE 17.96
Fwd PE 13.92
P/S 0.25
P/FCF 13.3
P/OCF 3.45
P/B 0.38
P/tB 0.88
EV/EBITDA 5.88
EPS(TTM)0.96
EY5.57%
EPS(NY)1.24
Fwd EY7.19%
FCF(TTM)1.3
FCFY7.52%
OCF(TTM)5
OCFY29.01%
SpS68.19
BVpS45.2
TBVpS19.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.25
Profitability
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.52%
FCFM 1.9%
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Debt/EBITDA 4.55
Cap/Depr 50.71%
Cap/Sales 5.43%
Interest Coverage N/A
Cash Conversion 81.82%
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.29
Altman-Z 1.88
F-Score6
WACC4.31%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
EPS Next Y-69.81%
EPS Next 2Y-11.44%
EPS Next 3Y7.01%
EPS Next 5Y11.66%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%
Revenue Next Year-8.19%
Revenue Next 2Y-3.81%
Revenue Next 3Y-1.46%
Revenue Next 5Y0.02%
EBIT growth 1Y82.42%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1115.36%
EBIT Next 3Y148.95%
EBIT Next 5Y77.72%
FCF growth 1Y-74.13%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-44.97%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%

LANXESS AG / LXS.DE FAQ

Can you provide the ChartMill fundamental rating for LANXESS AG?

ChartMill assigns a fundamental rating of 3 / 10 to LXS.DE.


What is the valuation status for LXS stock?

ChartMill assigns a valuation rating of 5 / 10 to LANXESS AG (LXS.DE). This can be considered as Fairly Valued.


What is the profitability of LXS stock?

LANXESS AG (LXS.DE) has a profitability rating of 2 / 10.


What is the financial health of LANXESS AG (LXS.DE) stock?

The financial health rating of LANXESS AG (LXS.DE) is 4 / 10.


Can you provide the expected EPS growth for LXS stock?

The Earnings per Share (EPS) of LANXESS AG (LXS.DE) is expected to decline by -69.81% in the next year.